将GAP粘在RAS突变体上:一种新方法解决癌症药物开发中的一个老问题
Ivan Ranđelović1, Kinga Nyíri2,3, Gergely Koppány2,3
1KINETO Lab Ltd., 1037 Budapest, Hungary.
International journal of molecular sciences
|March 13, 2024
概括
新的小分子在胰腺癌中有效抑制KRAS G12D突变. 这种新的方法通过粘合关键蛋白质来准难以治疗的瘤,为癌症药物开发提供了一个有希望的新途径.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 拉斯基因突变,特别是克拉斯基因突变,涉及约25%的人类瘤,推动致命癌症的发展.
- KRAS突变在难以治疗的胰腺,结直肠和肺腺癌中很普遍,通常对化疗有抗性.
- 突变的KRAS蛋白采用构造,破坏与GAP蛋白的相互作用,导致不受控制的细胞增殖.
研究的目的:
- 开发一种新的计算方法,用于识别向突变KRAS的小分子.
- 发现能够抑制KRAS驱动癌症的新治疗剂.
主要方法:
- 采用粘合对接方法来识别与突变的KRAS和GAP蛋白结合的小分子.
- 鉴定的化合物的疗效使用PANC-1细胞系进行了评估,该细胞系含有KRAS G12D突变.
- 进行了体外和体内研究,以评估对癌细胞生长的抑制作用.
主要成果:
- 通过粘合对接方法确定了两种新型药物样小分子.
- 这些化合物表现出具有KRAS G12D突变的PANC-1细胞系生长的特定抑制.
- 与已知的抑制剂MRTX-1133.3相比,这些新发现的化合物表现出更高的疗效和特异性.
结论:
- 粘合对接方法在发现突变KRAS的新型抑制剂方面是有效的.
- 已识别的小分子代表了治疗KRAS突变癌症,特别是胰腺癌的有希望的治疗候选者.
- 这种方法为开发针对以前难以治疗的瘤基因突变的药物提供了新的策略.
更多相关视频
相关概念视频
02:38The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
01:24Small GTPases - Ras and Rho
3.9K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
3.9K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K